These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
137 related articles for article (PubMed ID: 11266932)
61. Evaluation of a novel commercial assay for the determination of cyclosporine A, tacrolimus, sirolimus, and everolimus by liquid chromatography-tandem mass spectrometric assay. Becker S; Thiery J; Ceglarek U Ther Drug Monit; 2013 Feb; 35(1):129-32. PubMed ID: 23188181 [TBL] [Abstract][Full Text] [Related]
62. Analysis of cyclosporin A, tacrolimus, sirolimus, and everolimus in dried blood spot samples using liquid chromatography tandem mass spectrometry. den Burger JC; Wilhelm AJ; Chahbouni A; Vos RM; Sinjewel A; Swart EL Anal Bioanal Chem; 2012 Oct; 404(6-7):1803-11. PubMed ID: 22899246 [TBL] [Abstract][Full Text] [Related]
63. Severe everolimus-associated pneumonitis in a renal transplant recipient. Alexandru S; Ortiz A; Baldovi S; Milicua JM; Ruíz-Escribano E; Egido J; Plaza JJ Nephrol Dial Transplant; 2008 Oct; 23(10):3353-5. PubMed ID: 18658177 [TBL] [Abstract][Full Text] [Related]
64. The performance of five different dried blood spot cards for the analysis of six immunosuppressants. Koster RA; Botma R; Greijdanus B; Uges DR; Kosterink JG; Touw DJ; Alffenaar JW Bioanalysis; 2015; 7(10):1225-35. PubMed ID: 26045003 [TBL] [Abstract][Full Text] [Related]
65. Everolimus monotherapy or combined therapy in liver transplantation: indications and results. Alegre C; Jiménez C; Manrique A; Abradelo M; Calvo J; Loinaz C; García-Sesma A; Cambra F; Alvaro E; García M; Sanabria R; Justo I; Caso O; Moreno E Transplant Proc; 2013 Jun; 45(5):1971-4. PubMed ID: 23769086 [TBL] [Abstract][Full Text] [Related]
67. Influence of a novel rapamycin analogon SDZ RAD on endothelial tissue factor and adhesion molecule expression. Haubitz M; Brunkhorst R Transplant Proc; 2002 Jun; 34(4):1124-6. PubMed ID: 12072294 [No Abstract] [Full Text] [Related]
68. [Everolimus-associated pneumonitis in adult liver transplant recipient]. Marín-Gómez LM; Cordero-Matía E; Gómez-Bravo MÁ; Bernal-Bellido C Med Clin (Barc); 2010 Sep; 135(9):431-2. PubMed ID: 19819477 [No Abstract] [Full Text] [Related]
69. Coadministration of neoral and the novel rapamycin analog, SDZ RAD, to rat lung allograft recipients: potentiation of immunosuppressive efficacy and improvement of tolerability of staggered versus simultaneous treatment. Hausen B; Boeke K; Berry GJ; Segarra I; Benet LZ; Christians U; Morris RE Transplantation; 1999 Apr; 67(7):956-62. PubMed ID: 10221478 [TBL] [Abstract][Full Text] [Related]
70. Sensitive quantification of sirolimus and everolimus by LC-MS/MS with online sample cleanup. Mueller DM; Rentsch KM J Chromatogr B Analyt Technol Biomed Life Sci; 2010 Apr; 878(13-14):1007-12. PubMed ID: 20308022 [TBL] [Abstract][Full Text] [Related]
71. The effects of immunosuppressants on vascular function, systemic oxidative stress and inflammation in rats. Shing CM; Fassett RG; Brown L; Coombes JS Transpl Int; 2012 Mar; 25(3):337-46. PubMed ID: 22239125 [TBL] [Abstract][Full Text] [Related]
72. Everolimus is a potent inducer of erythroid differentiation and gamma-globin gene expression in human erythroid cells. Zuccato C; Bianchi N; Borgatti M; Lampronti I; Massei F; Favre C; Gambari R Acta Haematol; 2007; 117(3):168-76. PubMed ID: 17148936 [TBL] [Abstract][Full Text] [Related]
73. The effect of different immunosuppressants on alloantigen dependent and independent factors involved in the development of chronic rejection in an animal model. Cole O; Rigg K; Shehata M Ann R Coll Surg Engl; 2001 Jul; 83(4):235-43. PubMed ID: 11518369 [TBL] [Abstract][Full Text] [Related]
74. RAD in de novo renal transplantation: comparison of three doses on the incidence and severity of acute rejection. Kahan BD; Kaplan B; Lorber MI; Winkler M; Cambon N; Boger RS Transplantation; 2001 May; 71(10):1400-6. PubMed ID: 11391226 [TBL] [Abstract][Full Text] [Related]
75. Alterations in glucose metabolism by cyclosporine in rat brain slices link to oxidative stress: interactions with mTOR inhibitors. Christians U; Gottschalk S; Miljus J; Hainz C; Benet LZ; Leibfritz D; Serkova N Br J Pharmacol; 2004 Oct; 143(3):388-96. PubMed ID: 15339861 [TBL] [Abstract][Full Text] [Related]
76. Severe atopic dermatitis treated with everolimus. Van Velsen SG; Haeck IM; Bruijnzeel-Koomen CA J Dermatolog Treat; 2009; 20(6):365-7. PubMed ID: 19954394 [TBL] [Abstract][Full Text] [Related]
77. Effect of ERL080A, RAD, and Neoral on hamster-to-rat heart xenograft survival. Zhu T; Bradley A; White D; Chen ZK Transplant Proc; 2001; 33(7-8):3871-2. PubMed ID: 11750649 [No Abstract] [Full Text] [Related]
78. Comparison of everolimus-eluting and sirolimus-eluting coronary stents: 1-year outcomes from the Randomized Evaluation of Sirolimus-eluting Versus Everolimus-eluting stent Trial (RESET). Kimura T; Morimoto T; Natsuaki M; Shiomi H; Igarashi K; Kadota K; Tanabe K; Morino Y; Akasaka T; Takatsu Y; Nishikawa H; Yamamoto Y; Nakagawa Y; Hayashi Y; Iwabuchi M; Umeda H; Kawai K; Okada H; Kimura K; Simonton CA; Kozuma K; Circulation; 2012 Sep; 126(10):1225-36. PubMed ID: 22824435 [TBL] [Abstract][Full Text] [Related]
79. Absorption and intestinal metabolism of SDZ-RAD and rapamycin in rats. Crowe A; Bruelisauer A; Duerr L; Guntz P; Lemaire M Drug Metab Dispos; 1999 May; 27(5):627-32. PubMed ID: 10220493 [TBL] [Abstract][Full Text] [Related]